Patents by Inventor Christen ANDERSON

Christen ANDERSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of exendin and analogs thereof to delay or prevent cardiac remodeling
    Patent number: 8946149
    Abstract: The present invention relates generally to the novel use of cardioprotective incretin compounds (CICs) such as GLP-1 and exendin and agonists thereof, including analogs and derivatives to prevent, delay, attenuate, or ameliorate cardiac remodeling. The present invention relates to methods for using CICs for the treatment of conditions associated with cardiac remodeling. The present invention further relates to methods for using CICs for the reduction of the risk or severity of congestive heart failure.
    Type: Grant
    Filed: April 11, 2006
    Date of Patent: February 3, 2015
    Assignees: Amylin Pharmaceuticals, LLC, AstraZeneca Pharmaceuticals LP
    Inventors: Christen Anderson, Que Liu
  • METHODS FOR TREATING OBESITY AND OBESITY RELATED DISEASES AND DISORDERS
    Publication number: 20100323955
    Abstract: Methods for treating obesity or obesity related disorders are disclosed. These methods include the use of anti-obesity agents directed to the forebrain in combination with anti-obesity agents directed to the hindbrain.
    Type: Application
    Filed: November 14, 2007
    Publication date: December 23, 2010
    Applicant: AMYLIN PHARMACEUTICALS, INC.
    Inventors: Jonathan David Roth, Alain D. Baron, Christen Anderson
  • USE OF GLP-1 AND AGONISTS THEREOF TO PREVENT CARDIAC MYOCYTE APOPTOSIS
    Publication number: 20090264352
    Abstract: The present invention relates generally to the novel use of GLP-1, including analogs, and agonists, to prevent cardiac myocyte apoptosis. The present invention relates to methods for using GLP-1 for the treatment of conditions associated with cardiac myocyte apoptosis. The present invention further relates to improving the efficiency of cardiac myocytes and also to improving cardiac contractility.
    Type: Application
    Filed: June 17, 2009
    Publication date: October 22, 2009
    Inventors: Christen ANDERSON, Alain D. Baron
  • Use of GLP-1, Exendin and Agonists Thereof To Delay or Prevent Cardiac Remodeling
    Publication number: 20090137466
    Abstract: The present invention relates generally to the novel use of cardioprotective incretin compounds (CICs) such as GLP-1 and exendin and agonists thereof, including analogs and derivatives to prevent, delay, attenuate, or ameliorate cardiac remodeling. The present invention relates to methods for using CICs for the treatment of conditions associated with cardiac remodeling. The present invention further relates to methods for using CICs for the reduction of the risk or severity of congestive heart failure.
    Type: Application
    Filed: April 11, 2006
    Publication date: May 28, 2009
    Applicant: Amylin Pharmaceuticals, Inc.
    Inventors: Christen Anderson, Que Liu
  • Use of GLP-1 and agonists thereof to prevent cardiac myocyte apoptosis
    Publication number: 20070021336
    Abstract: The present invention relates generally to the novel use of GLP-1, including analogs, and agonists, to prevent cardiac myocyte apoptosis. The present invention relates to methods for using GLP-1 for the treatment of conditions associated with cardiac myocyte apoptosis. The present invention further relates to improving the efficiency of cardiac myocytes and also to improving cardiac contractility.
    Type: Application
    Filed: December 22, 2005
    Publication date: January 25, 2007
    Inventors: Christen Anderson, Alain Baron
  • PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR
    Publication number: 20050064530
    Abstract: Compositions and methods are provided for producing adenine nucleotide translocator (ANT) polypeptides and fusion proteins, including the production and use of recombinant expression constructs having a regulated promoter. ANT ligands and compositions and methods for identifying ANT ligands, agents that bind ANT and agents that interact with ANT are also disclosed.
    Type: Application
    Filed: March 14, 2001
    Publication date: March 24, 2005
    Inventors: Christen Anderson, Robert Davis, Tomas Szabo, Soumitra Ghosh, Walter Moos, Yazhong Pei
  • PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR
    Publication number: 20050019835
    Abstract: Compositions and methods are provided for producing adenine nucleotide translocator (ANT) polypeptides and fusion proteins, including the production and use of recombinant expression constructs having a regulated promoter. ANT ligands and compositions and methods for identifying ANT ligands, agents that bind ANT and agents that interact with ANT are also disclosed.
    Type: Application
    Filed: March 14, 2001
    Publication date: January 27, 2005
    Inventors: Christen Anderson, Robert Davis, William Clevenger, Sandra Wiley, Scott Miller, Tomas Szabo, Soumitra Ghosh, Walter Moos, Yazhong Pei
  • PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR
    Publication number: 20050003353
    Abstract: Compositions and methods are provided for producing adenine nucleotide translocator (ANT) polypeptides and fusion proteins, including the production and use of recombinant expression constructs having a regulated promoter. ANT ligands and compositions and methods for identifying ANT ligands, agents that bind ANT and agents that interact with ANT are also disclosed.
    Type: Application
    Filed: March 16, 2001
    Publication date: January 6, 2005
    Inventors: Christen Anderson, Robert Davis, William Clevenger, Sandra Wiley, Scott Miller, Tomas Szabo, Soumitra Ghosh, Walter Moos, Yazhong Pei
  • PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR
    Publication number: 20050003352
    Abstract: Compositions and methods are provided for producing adenine nucleotide translocator (ANT) polypeptides and fusion proteins, including the production and use of recombinant expression constructs having a regulated promoter. ANT ligands and compositions and methods for identifying ANT ligands, agents that bind ANT and agents that interact with ANT are also disclosed.
    Type: Application
    Filed: March 16, 2001
    Publication date: January 6, 2005
    Inventors: Christen Anderson, Robert Davis, William Clevenger, Sandra Wiley, Scott Miller, Tomas Szabo, Soumitra Ghosh, Walter Moos, Yazhong Pei